Head to Head Comparison of Azacitidine and Decitabine in Myelodysplastic Syndrome: Retrospective, Multicenter Study
Among 300 MDS patient, 200 of them have been taking Azacitidine and 100 of them have been
taking Decitabine. Medical chart of these patients will be reviewed to assess the efficacy
and safety between two agents.
Observational Model: Cohort, Time Perspective: Retrospective
Compare Azacitidine and Decitabine's treatment response rate in MDS patients
Korea: Institutional Review Board